Multi-Specific Antibodies For HIV-1 And Their Utility Read more about Multi-Specific Antibodies For HIV-1 And Their Utility US Application 62/749,510Filed on 2018-10-23
Multi-Specific Antibodies For HIV-1 And Their Utility Read more about Multi-Specific Antibodies For HIV-1 And Their Utility US Application 62/748,228Filed on 2018-10-19
NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US Application 62/775,754Filed on 2018-12-05
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN Read more about CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN US Application 61/858,533Filed on 2013-07-25
EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF Read more about EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF US Application 62/782,809Filed on 2018-12-20
HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Read more about HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE US Application 62/735,188Filed on 2018-09-23
USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION Read more about USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION US Application 62/737,899Filed on 2018-09-27
Improved Methods Of Manufacturing Peptide-Based Vaccines Read more about Improved Methods Of Manufacturing Peptide-Based Vaccines US Application 62/674,752Filed on 2018-05-22
A HIGH-YIELD PERFUSION-BASED TRANSIENT GENE EXPRESSION BIOPROCESS Read more about A HIGH-YIELD PERFUSION-BASED TRANSIENT GENE EXPRESSION BIOPROCESS US Application 62/751,204Filed on 2018-10-26
NEW COMPOSITIONS AND DETECTION METHODS FOR ONCHOCERCA VOLVULUS INFECTION Read more about NEW COMPOSITIONS AND DETECTION METHODS FOR ONCHOCERCA VOLVULUS INFECTION US Application 62/682,678Filed on 2018-06-08